NICE has welcomed the inclusion of a rules-Based pathway for medical technologies in the government's upcoming NHS 10 year health plan.

MASLD, a liver disease linked to obesity and poor lifestyle, is rising among children. Often symptomless early on, it can ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant ...

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised multidisciplinary treatments, at a cost.

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

Patients with only dry eye had less severe lid margin abnormalities and orifice plugging along with tear film instability ...

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

Type 1 diabetes affects over 8 million people around the world. It’s a lifelong condition that occurs when the immune system ...